Literature DB >> 27813515

Elbow splinting as a method to increase patching compliance in amblyopia therapy.

K Sabri1,2,3, B Easterbrook2, B Wakeman4,5, V Mehta6, R Riyaz5.   

Abstract

PurposeThe purpose of the study was to evaluate the feasibility and acceptability of utilizing elbow splints as a method of increasing amblyopic patching compliance in pediatric ophthalmology patients who fail to comply with prescribed patching regimens.Patients and methodsPatients <6 years of age who were not adhering to pre-specified patching guidelines were prescribed elbow splints in order to increase patching compliance at the discretion of a pediatric ophthalmologist. If the child was non-compliant (patching <50% of specified time or consistently removing patch), parents were asked to try using the elbow splints until patching compliance was achieved. Non-parametric Wilcoxon signed-rank tests were used to compare patching time pre- and post-splints.Results41/48 children who were prescribed elbow splints to increase patching compliance for amblyopia were included for analysis. Seven children were excluded due to patching and splints being prescribed at the outset (n=4), and for not using the splinting intervention (n=3). Median age at being prescribed elbow splints was 37 (12-68) months. Mean daily patching prior to splints was 1.5±1.7 h, whereas mean prescribed daily patching was 4.95±1.5 h. Following splinting, 34/41 (83%) became compliant with patch alone, and visual acuity increased in 39/41 (95%) patients, with no patients developing amblyopia in the fellow eye. Median amount of time splints was required to improve compliance was 7 (1-240) days.ConclusionElbow splinting seems to be a viable alternative method to increase pediatric amblyopic patching compliance when patching alone fails to achieve satisfactory compliance.

Entities:  

Mesh:

Year:  2016        PMID: 27813515      PMCID: PMC5350358          DOI: 10.1038/eye.2016.222

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  8 in total

1.  Risk of bilateral visual impairment in individuals with amblyopia: the Rotterdam study.

Authors:  Redmer van Leeuwen; Marinus J C Eijkemans; Johannes R Vingerling; Albert Hofman; Paulus T V M de Jong; Huib J Simonsz
Journal:  Br J Ophthalmol       Date:  2007-05-23       Impact factor: 4.638

2.  Glued patches for children resistant to amblyopia occlusion therapy.

Authors:  Shehla Rubab; Dana French; Alex V Levin
Journal:  Arch Ophthalmol       Date:  2008-01

3.  Compliance in amblyopia therapy: objective monitoring of occlusion.

Authors:  A R Fielder; M Irwin; R Auld; K D Cocker; H S Jones; M J Moseley
Journal:  Br J Ophthalmol       Date:  1995-06       Impact factor: 4.638

4.  Mechanisms of amblyopia.

Authors:  G K Noorden
Journal:  Adv Ophthalmol       Date:  1977

5.  Electronic monitoring of treatment compliance in patching for amblyopia.

Authors:  H J Simonsz; J R Polling; R Voorn; J van Leeuwen; H Meester; C Romijn; B G Dijkstra
Journal:  Strabismus       Date:  1999-06

6.  Compliance with occlusion therapy for childhood amblyopia.

Authors:  Michael P Wallace; Catherine E Stewart; Merrick J Moseley; David A Stephens; Alistair R Fielder
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-09-17       Impact factor: 4.799

7.  A randomized trial of atropine vs. patching for treatment of moderate amblyopia in children.

Authors: 
Journal:  Arch Ophthalmol       Date:  2002-03

8.  Occlusion therapy of unilateral amblyopia with botulinum toxin induced ptosis.

Authors:  Ioannis Halkiadakis; Olga Iliaki; Maria I Kalyvianaki; Miltiadis K Tsilimbaris
Journal:  Semin Ophthalmol       Date:  2007 Jan-Mar       Impact factor: 1.975

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.